285 related articles for article (PubMed ID: 9131485)
1. The human drug metabolizing cytochromes P450.
Wrighton SA; VandenBranden M; Ring BJ
J Pharmacokinet Biopharm; 1996 Oct; 24(5):461-73. PubMed ID: 9131485
[TBL] [Abstract][Full Text] [Related]
2. Overview of enzymes of drug metabolism.
Meyer UA
J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
[TBL] [Abstract][Full Text] [Related]
3. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
[TBL] [Abstract][Full Text] [Related]
4. The human hepatic cytochromes P450 involved in drug metabolism.
Wrighton SA; Stevens JC
Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
Wilkinson GR
J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
[TBL] [Abstract][Full Text] [Related]
6. In vitro techniques for studying drug metabolism.
Guengerich FP
J Pharmacokinet Biopharm; 1996 Oct; 24(5):521-33. PubMed ID: 9131489
[TBL] [Abstract][Full Text] [Related]
7. Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?
Tang C; Lin JH; Lu AY
Drug Metab Dispos; 2005 May; 33(5):603-13. PubMed ID: 15673596
[TBL] [Abstract][Full Text] [Related]
8. Predicting clearance in humans from in vitro data.
Obach RS
Curr Top Med Chem; 2011; 11(4):334-9. PubMed ID: 21320062
[TBL] [Abstract][Full Text] [Related]
9. Sulfenylation of Human Liver and Kidney Microsomal Cytochromes P450 and Other Drug-Metabolizing Enzymes as a Response to Redox Alteration.
Albertolle ME; Phan TTN; Pozzi A; Guengerich FP
Mol Cell Proteomics; 2018 May; 17(5):889-900. PubMed ID: 29374135
[TBL] [Abstract][Full Text] [Related]
10. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
Yamazaki H
Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of the cytochromes P450.
Daly AK
Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
[TBL] [Abstract][Full Text] [Related]
12. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
[TBL] [Abstract][Full Text] [Related]
13. Drug metabolism by Escherichia coli expressing human cytochromes P450.
Parikh A; Gillam EM; Guengerich FP
Nat Biotechnol; 1997 Aug; 15(8):784-8. PubMed ID: 9255795
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A.
Ring BJ; Parli CJ; George MC; Wrighton SA
Drug Metab Dispos; 1994; 22(3):352-7. PubMed ID: 8070310
[TBL] [Abstract][Full Text] [Related]
15. Structural modelling of the human drug-metabolizing cytochromes P450.
Lewis DF; Ito Y; Goldfarb PS
Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
17. 57 varieties: the human cytochromes P450.
Lewis DF
Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
[TBL] [Abstract][Full Text] [Related]
18. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: time dependency and reversibility profiles in isolated perfused rat livers.
Vuppugalla R; Mehvar R
Drug Metab Dispos; 2004 Dec; 32(12):1446-54. PubMed ID: 15383494
[TBL] [Abstract][Full Text] [Related]
19. Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space.
Reinen J; van Leeuwen JS; Li Y; Sun L; Grootenhuis PD; Decker CJ; Saunders J; Vermeulen NP; Commandeur JN
Drug Metab Dispos; 2011 Sep; 39(9):1568-76. PubMed ID: 21673132
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Drug Metabolism Using Liver Microsomes.
Knights KM; Stresser DM; Miners JO; Crespi CL
Curr Protoc Pharmacol; 2016 Sep; 74():7.8.1-7.8.24. PubMed ID: 27636111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
